A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Brain disorders like Parkinson's or Alzheimer's Disease start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or ...

Researchers have developed a method to analyze extracellular vesicles (EVs) in blood for early detection of Parkinson’s ...

Signs of PD start slow but become more frequent and intense as the disease progresses. It's important for both patient and caregiver to know the stages of PD and how it progresses in order to know ...

These investigational agents target the key mechanisms that have been implicated in the pathophysiology of PD, such as alpha-synuclein aggregation and neuroinflammation, with the goal of slowing ...

But experts tend to refer to five different stages. Stage 1: This is considered early-stage Parkinson's disease, usually involving mild symptoms that do not impact daily activities. Stage 2 ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...